Number of cerebral microbleeds and risk of intracerebral hemorrhage after intravenous thrombolysis

Stroke

Volumn 45, Issue 10, 2014, Pages 2900-2905

  Dannenberg, Steffen ^a   Scheitz, Jan F ^a   Rozanski, Michal ^a   Erdur, Hebun ^a   Brunecker, Peter ^a   Werring, David J ^b,c   Fiebach, Jochen B ^a   Nolte, Christian H ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

cerebral hemorrhage; cerebral microbleeds; cerebral small vessel diseases; magnetic resonance imaging; stroke; thrombolytic therapy

Indexed keywords

ALTEPLASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; FIBRINOLYTIC AGENT;

AGED; ARTICLE; ATRIAL FIBRILLATION; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OUTCOME ASSESSMENT; PARENCHYMAL HEMORRHAGE; PRIORITY JOURNAL; RANKIN SCALE; SYSTOLIC BLOOD PRESSURE; TIME TO TREATMENT; VERY ELDERLY; WHITE MATTER; ADVERSE EFFECTS; BRAIN; CAPILLARY; CEREBRAL HEMORRHAGE; CHEMICALLY INDUCED; FIBRINOLYTIC THERAPY; INTRAVENOUS DRUG ADMINISTRATION; PATHOLOGY; RISK; STROKE;

ADMINISTRATION, INTRAVENOUS; AGED; AGED, 80 AND OVER; BRAIN; CAPILLARIES; CEREBRAL HEMORRHAGE; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; RISK; STROKE; THROMBOLYTIC THERAPY;

EID: 84922449350     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.006448     Document Type: Article

References (33)

1. Seet RC, Rabinstein AA. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: A critical review of case definitions. Cerebrovasc Dis. 2012;34:106-114.
2. Strbian D, Sairanen T, Meretoja A, Pitkäniemi J, Putaala J, Salonen O, et al; Helsinki Stroke Thrombolysis Registry Group. Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis. Neurology. 2011;77:341-348.
3. Derex L, Nighoghossian N. Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: An update. J Neurol Neurosurg Psychiatry. 2008;79:1093-1099.
4. Charidimou A, Kakar P, Fox Z, Werring DJ. Cerebral microbleeds and the risk of intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2013;84:277-280.
5. Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-Shahi Salman R, Warach S, et al; Microbleed Study Group. Cerebral microbleeds: A guide to detection and interpretation. Lancet Neurol. 2009;8: 165-174.
6. Shoamanesh A, Kwok CS, Benavente O. Cerebral microbleeds: histopathological correlation of neuroimaging. Cerebrovasc Dis. 2011;32:528-534.
7. Park JH, Seo SW, Kim C, Kim GH, Noh HJ, Kim ST, et al. Pathogenesis of cerebral microbleeds: in vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment. Ann Neurol. 2013;73:584-593.
8. Charidimou A, Kakar P, Fox Z, Werring DJ. Cerebral microbleeds and recurrent stroke risk: systematic review and meta-analysis of prospective ischemic stroke and transient ischemic attack cohorts. Stroke. 2013;44:995-1001.
9. Charidimou A, Fox Z, Werring DJ. Do cerebral microbleeds increase the risk of intracerebral hemorrhage after thrombolysis for acute ischemic stroke? Int J Stroke. 2013;8:E1-E2.
10. Fiehler J, Albers GW, Boulanger JM, Derex L, Gass A, Hjort N, et al; MR STROKE Group. Bleeding risk analysis in stroke imaging before thromboLysis (BRASIL): pooled analysis of T2∗-weighted magnetic resonance imaging data from 570 patients. Stroke. 2007;38:2738-2744.
11. Derex L, Nighoghossian N, Hermier M, Adeleine P, Philippeau F, Honnorat J, et al. Thrombolysis for ischemic stroke in patients with old microbleeds on pretreatment MRI. Cerebrovasc Dis. 2004;17:238-241.
12. Kakuda W, Thijs VN, Lansberg MG, Bammer R, Wechsler L, Kemp S, et al; DEFUSE Investigators. Clinical importance of microbleeds in patients receiving IV thrombolysis. Neurology. 2005;65:1175-1178.
13. Kato H, Izumiyama M, Izumiyama K, Takahashi A, Itoyama Y. Silent cerebral microbleeds on T2∗-weighted MRI: correlation with stroke subtype, stroke recurrence, and leukoaraiosis. Stroke. 2002;33:1536-1540.
14. Kidwell CS, Saver JL, Villablanca JP, Duckwiler G, Fredieu A, Gough K, et al. Magnetic resonance imaging detection of microbleeds before thrombolysis: An emerging application. Stroke. 2002;33:95-98.
15. Kim HS, Lee DH, Ryu CW, Lee JH, Choi CG, Kim SJ, et al. Multiple cerebral microbleeds in hyperacute ischemic stroke: impact on prevalence and severity of early hemorrhagic transformation after thrombolytic treatment. AJR Am J Roentgenol. 2006;186:1443-1449.
16. Nighoghossian N, Hermier M, Adeleine P, Blanc-Lasserre K, Derex L, Honnorat J, et al. Old microbleeds are a potential risk factor for cerebral bleeding after ischemic stroke: A gradient-echo T2∗-weighted brain MRI study. Stroke. 2002;33:735-742.
17. Shoamanesh A, Kwok CS, Lim PA, Benavente OR. Postthrombolysis intracranial hemorrhage risk of cerebral microbleeds in acute stroke patients: A systematic review and meta-analysis. Int J Stroke. 2013;8:348-356.
18. Gratz PP, El-Koussy M, Hsieh K, von Arx S, Mono ML, Heldner MR, et al. Preexisting cerebral microbleeds on susceptibility-weighted magnetic resonance imaging and post-thrombolysis bleeding risk in 392 patients. Stroke. 2014;45:1684-1688.
19. Tütüncü S, Ziegler AM, Scheitz JF, Slowinski T, Rocco A, Endres M, et al. Severe renal impairment is associated with symptomatic intracerebral hemorrhage after thrombolysis for ischemic stroke. Stroke. 2013;44:3217-3219.
20. Thomalla G, Cheng B, Ebinger M, Hao Q, Tourdias T, Wu O, et al; STIR and VISTA Imaging Investigators. DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4. 5 h of symptom onset (PRE-FLAIR): A multicentre observational study. Lancet Neurol. 2011;10:978-986.
21. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjögren M, et al; European Task Force on Age-Related White Matter Changes. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke. 2001;32:1318-1322.
22. Hotter B, Pittl S, Ebinger M, Oepen G, Jegzentis K, Kudo K, et al. Prospective study on the mismatch concept in acute stroke patients within the first 24 h after symptom onset-1000Plus study. BMC Neurol. 2009;9:60.
23. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al; STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822-838.
24. Knudsen KA, Rosand J, Karluk D, Greenberg SM. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology. 2001;56:537-539.
25. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al; ECASS Investigators. Thrombolysis with alteplase 3 to 4. 5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317-1329.
26. Fiorelli M, Bastianello S, von Kummer R, del Zoppo GJ, Larrue V, Lesaffre E, et al. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke. 1999;30:2280-2284.
27. Stehling C, Wersching H, Kloska SP, Kirchhof P, Ring J, Nassenstein I, et al. Detection of asymptomatic cerebral microbleeds: A comparative study at 1. 5 and 3. 0 T. Acad Radiol. 2008;15:895-900.
28. Vernooij MW, van der Lugt A, Ikram MA, Wielopolski PA, Niessen WJ, Hofman A, et al. Prevalence and risk factors of cerebral microbleeds: The Rotterdam Scan Study. Neurology. 2008;70:1208-1214.
29. McCarron MO, Nicoll JA. Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage. Lancet Neurol. 2004;3:484-492.
30. Scheitz JF, Seiffge DJ, Tütüncü S, Gensicke H, Audebert HJ, Bonati LH, et al. Dose-related effects of statins on symptomatic intracerebral hemorrhage and outcome after thrombolysis for ischemic stroke. Stroke. 2014;45:509-514.
31. Mazya M, Egido JA, Ford GA, Lees KR, Mikulik R, Toni D, et al; SITS Investigators. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score. Stroke. 2012;43:1524-1531.
32. Gerischer LM, Fiebach JB, Scheitz JF, Audebert HJ, Endres M, Nolte CH. Magnetic resonance imaging-based versus computed tomographybased thrombolysis in acute ischemic stroke: comparison of safety and efficacy within a cohort study. Cerebrovasc Dis. 2013;35:250-256.
33. Singer OC, Humpich MC, Fiehler J, Albers GW, Lansberg MG, Kastrup A, et al; MR Stroke Study Group Investigators. Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusionweighted magnetic resonance imaging. Ann Neurol. 2008;63:52-60.